IP Library Granted Patent US 7,955,615
Granted Patent B2
US 7,955,615 · App. 11/212,376 · Granted Jun 7, 2011

Polycationic peptide coatings and methods of coating implantable medical devices

Assignee: Advanced Cardiovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,955,615
App. No.
11/212,376
Granted
Jun 7, 2011
Kind
B2
Abstract

Coatings for medical devices which include polycationic peptides such as L-arginine and methods for fabricating the coatings are disclosed.

Claims (8)

1. A coating for an implantable medical device, wherein the coating comprises a polymer and a complex comprising a polycationic peptide and a counter-ion, wherein the complex is bonded to the polymer.

2. The coating of claim 1 , wherein the medical device comprises a stent.

3. The coating of claim 1 , wherein the polymer comprises a component selected from a group consisting of hydroxyl, glycidyl, amino, carboxyl, or aldehyde functional groups, and a combination thereof.

4. The coating of claim 1 , wherein the polymer comprises a component selected from a group consisting of poly(ethylene-co-vinyl alcohol), poly(butylmethacrylate-co-2-hydroxyethyl methacrylate), poly(butylmethacrylate-co-acrylic acid), poly(ethylene glycol), poly(ethylene-co-glycidyl methacrylate), poly(ethyleneimine), poly(ethylene-co-acrylic acid), and a combination thereof.

5. The coating of claim 1 , wherein the polycationic peptide comprises a component selected from a group consisting of poly(L-arginine), poly(D-arginine), poly(D,L-arginine), poly(L-lysine), poly(D-lysine), poly(δ-guanidino-α-aminobutyric acid), mixtures of poly(L-arginine) and poly(D-arginine), chitosan, and a combination thereof.

6. The coating of claim 1 , wherein the counter-ion comprises an anionic polysaccharide, an anionic hydrogel, or a combination thereof.

7. The coating of claim 6 , wherein the anionic polysaccharide comprises a component selected from a group consisting of heparin, a heparin salt, a heparinoid, dermatan sulfate, keratan sulfate, chondroitin sulfate, hyaluronic acid, a hyaluronate, and a combination thereof.

8. The coating of claim 6 , wherein the anionic hydrogel comprises a component selected from a group consisting of sulfated poly(ethylene glycol), sulfonated poly(ethylene glycol), carboxylated poly(ethylene glycol), and combinations thereof.

Continuity (2)
Division 10177116 · Jun 21, 2002
Related Publication 20060002974A1 · Jan 5, 2006